Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in
Adult
Aged
Bacterial Proteins
/ genetics
Carbapenems
/ pharmacology
Cyprus
Drug Resistance, Multiple, Bacterial
Enterobacteriaceae
/ classification
Feces
/ microbiology
Female
Fluoroquinolones
/ pharmacology
Gastrointestinal Microbiome
/ drug effects
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Plasmids
/ genetics
Risk Factors
Young Adult
beta-Lactamases
/ genetics
Antibiotic resistance
Carbapenem resistance
Ciprofloxacin resistance
Enterobacteriaceae
Extended-spectrum beta lactamase
Fecal carriage
Northern Cyprus
Plasmid-mediated AmpC beta-lactamase
Journal
Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
11
2018
accepted:
26
05
2019
entrez:
15
6
2019
pubmed:
15
6
2019
medline:
17
6
2020
Statut:
epublish
Résumé
Antibiotic-resistant A total of 500 community-dwellers were recruited from consecutive admissions to the clinical laboratories of four hospitals. One rectal swab or stool sample was collected from each participant. A questionnaire was applied to evaluate possible risk factors associated with intestinal colonization of resistant bacteria. The samples were cultured on antibiotic containing media to screen for resistant bacteria colonization. The bacterial colonies that grew on the plates were subjected to further phenotypic tests to confirm the resistance. Of 500 volunteers, ESBL-E, pAmpC-E, CIP-RE and CIRE carriage were detected in 107 (21.4%), 15 (3.0%), 51 (10.2%) and six (1.2%) participants, respectively. The study indicates that resistant
Sections du résumé
Background
Antibiotic-resistant
Methods
A total of 500 community-dwellers were recruited from consecutive admissions to the clinical laboratories of four hospitals. One rectal swab or stool sample was collected from each participant. A questionnaire was applied to evaluate possible risk factors associated with intestinal colonization of resistant bacteria. The samples were cultured on antibiotic containing media to screen for resistant bacteria colonization. The bacterial colonies that grew on the plates were subjected to further phenotypic tests to confirm the resistance.
Results
Of 500 volunteers, ESBL-E, pAmpC-E, CIP-RE and CIRE carriage were detected in 107 (21.4%), 15 (3.0%), 51 (10.2%) and six (1.2%) participants, respectively.
Conclusion
The study indicates that resistant
Identifiants
pubmed: 31198531
doi: 10.1186/s13756-019-0548-9
pii: 548
pmc: PMC6558775
doi:
Substances chimiques
Bacterial Proteins
0
Carbapenems
0
Fluoroquinolones
0
AmpC beta-lactamases
EC 3.5.2.6
beta-Lactamases
EC 3.5.2.6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
98Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
J Infect Dev Ctries. 2017 Feb 28;11(2):188-191
pubmed: 28248681
J Infect. 2016 Jul 5;72 Suppl:S41-9
pubmed: 27180312
Antimicrob Resist Infect Control. 2016 Aug 05;5:29
pubmed: 27499852
Trends Mol Med. 2012 May;18(5):263-72
pubmed: 22480775
Antimicrob Agents Chemother. 2013 Oct;57(10):5131-3
pubmed: 23836188
PLoS One. 2016 Dec 12;11(12):e0167885
pubmed: 27941993
Antimicrob Resist Infect Control. 2017 Jun 13;6:62
pubmed: 28630686
PLoS One. 2015 Jan 14;10(1):e0113033
pubmed: 25587716
J Pharm Technol. 2016 Feb;32(1):16-21
pubmed: 34860959
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
PLoS One. 2017 Nov 7;12(11):e0187618
pubmed: 29112974
Front Microbiol. 2016 Jan 13;6:1446
pubmed: 26793167
Infect Genet Evol. 2015 Mar;30:8-14
pubmed: 25444940
Clin Microbiol Infect. 2017 Feb;23(2):120.e1-120.e8
pubmed: 27773759
J Antimicrob Chemother. 2014 Dec;69(12):3393-400
pubmed: 25063781
PLoS One. 2015 Jun 01;10(6):e0129085
pubmed: 26029910
Clin Microbiol Rev. 2013 Oct;26(4):744-58
pubmed: 24092853
Niger J Clin Pract. 2018 Jan;21(1):81-86
pubmed: 29411729
J Clin Microbiol. 2010 Apr;48(4):1019-25
pubmed: 20181902
Clin Microbiol Infect. 2016 Aug;22(8):731.e1-7
pubmed: 27223840
Mikrobiyol Bul. 2014 Jan;48(1):59-69
pubmed: 24506716
J Clin Microbiol. 2012 May;50(5):1558-63
pubmed: 22403422
J Infect Dis. 2015 Dec 15;212(12):1862-8
pubmed: 25969564
Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2215-21
pubmed: 24993152
Clin Microbiol Infect. 2013 Jun;19(6):542-9
pubmed: 22757622
J Clin Microbiol. 2009 Jun;47(6):1631-9
pubmed: 19386850
Clin Microbiol Infect. 2012 Jun;18(6):575-81
pubmed: 21958149
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents
pubmed: 19136439
J Hosp Infect. 2016 Jan;92(1):78-81
pubmed: 26615459
J Hosp Infect. 2017 Nov;97(3):212-217
pubmed: 28736270
PLoS One. 2015 Oct 02;10(10):e0139883
pubmed: 26431402
Int J Infect Dis. 2016 Apr;45:24-31
pubmed: 26899954
Antimicrob Agents Chemother. 2010 Dec;54(12):5193-200
pubmed: 20876373
Curr Infect Dis Rep. 2018 Mar 23;20(5):7
pubmed: 29572691
Urology. 2012 Mar;79(3):556-61
pubmed: 22386395
Ann Lab Med. 2015 May;35(3):298-305
pubmed: 25932437
J Antimicrob Chemother. 2012 Jul;67(7):1769-74
pubmed: 22514260
J Microbiol Methods. 2018 Sep;152:154-164
pubmed: 30063958
J Clin Microbiol. 2012 Sep;50(9):3016-22
pubmed: 22760052
J Antimicrob Chemother. 2016 Apr;71(4):1076-82
pubmed: 26755493
J Clin Microbiol. 2014 May;52(5):1483-9
pubmed: 24574283
PLoS One. 2016 Aug 30;11(8):e0161685
pubmed: 27574974